ETR:SAZ STADA Arzneimittel Aktiengesellschaft (SAZ) Stock Price, News & Analysis → The Only Energy Play You Should Be Looking At (From Wealthpin Pro) (Ad) Free SAZ Stock Alerts €80.40 0.00 (0.00%) (As of 11/27/2018) Add Compare Share Share Today's Range€79.56▼€80.9850-Day Range€80.40▼€80.4052-Week Range€53.41▼€80.98Volume92,068 shsAverage Volume51,761 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get STADA Arzneimittel Aktiengesellschaft alerts: Email Address Ad Colonial MetalsCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar. For one main reason.In answer to this issue, we have released a Special Report to the public. About STADA Arzneimittel Aktiengesellschaft Stock (ETR:SAZ)STADA Arzneimittel Aktiengesellschaft engages in the development and marketing of pharmaceutical products for the health care and pharmaceutical markets worldwide. It operates through two segments, Generics and Branded Products. The Generics segment provides various generic active ingredients, including Tilidin Naloxone for pain; Atorvastatin for elevated cholesterol levels; Epoetin zeta for anemia; Diclofenac for pain/inflammation; and Pantoprazole for gastric ulcer/reflux. The Branded Products segment offers APO-Go a Parkinson's medicine; Grippostad a cold medicine; Aqualor for rhinitis/sore throat; Snup for rhinitis; and Vitaprost for prostate disease indications. The company is also involved in the wholesale activities in the pharmaceutical market. It serves patients and consumers, doctors, pharmacies and pharmacy chains, hospitals, mail-order companies, buying groups, wholesalers, and other service providers in the health care market, as well as public or private health insurance organizations. The company was founded in 1895 and is headquartered in Bad Vilbel, Germany. STADA Arzneimittel Aktiengesellschaft is a subsidiary of Nidda Healthcare Holding GmbH.Read More SAZ Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SAZ Stock News HeadlinesApril 11, 2024 | finanznachrichten.deIPO/Kreise: Stada-Eigner bereden erneuten Börsengang und VerkaufsoptionenApril 11, 2024 | finanznachrichten.deIPO/Kreise: Stada-Eigner bereden erneuten Börsengang und VerkaufsoptionenDecember 27, 2023 | finanznachrichten.deArzneihersteller Stada hat Russland-Geschäft abgespaltenNovember 5, 2023 | seekingalpha.comBayerische Motoren Werke Aktiengesellschaft 2023 Q3 - Results - Earnings Call PresentationApril 9, 2023 | finance.yahoo.comBasler Aktiengesellschaft (ETR:BSL) Consensus Forecasts Have Become A Little Darker Since Its Latest ReportApril 6, 2023 | finanznachrichten.dePTA-HV: Deutsche Real Estate Aktiengesellschaft: -3-April 6, 2023 | reuters.comSTADA Arzneimittel AGFebruary 25, 2023 | msn.comHOCHTIEF Aktiengesellschaft Non-GAAP EPS of €1.68, revenue of €7.09BFebruary 22, 2023 | finanznachrichten.deAktuelle Empfehlungen zur STADA ARZNEIMITTELDecember 1, 2022 | finance.yahoo.comIs There An Opportunity With InVision Aktiengesellschaft's (ETR:IVX) 49% Undervaluation?October 30, 2022 | seekingalpha.comOMV Aktiengesellschaft (OMVJF) Q3 2022 Earnings Call TranscriptOctober 30, 2022 | finanznachrichten.deEQS-News: Lloyd Fonds Aktiengesellschaft: Barkapitalerhöhung erfolgreich umgesetztSeptember 14, 2022 | thestreet.comStada Arzneimittel Shares Tumble After $6 Billion Civen/Bain Takeover CollapseSee More Headlines Receive SAZ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for STADA Arzneimittel Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeETR SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolETR:SAZ CUSIPN/A CIKN/A Webwww.stada.de Phone+49-6101-6030FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Mark Burgess Keatley MBA (Age 61)MA, MPhil, CFO & Member of Exec. Board Mr. Peter Goldschmidt (Age 54)Chairman of the Exec. Board & CEO Mr. Miguel Pagan Fernandez (Age 53)CTO & Member of Exec. Board Mr. Sebastian Kramer-Bach (Age 43)Exec. VP of Corp. Communication Ms. Kay ReubeltDirector of Investor RelationsKey CompetitorsTeva Pharmaceutical IndustriesFRA:TEVMerck KGaAETR:MRKEvotecETR:EVTEssilor International Société AnonymeEPA:EIFielmann GroupFRA:FIEView All Competitors SAZ Stock Analysis - Frequently Asked Questions How have SAZ shares performed in 2024? STADA Arzneimittel Aktiengesellschaft's stock was trading at €80.40 on January 1st, 2024. Since then, SAZ stock has increased by 0.0% and is now trading at €80.40. View the best growth stocks for 2024 here. What other stocks do shareholders of STADA Arzneimittel Aktiengesellschaft own? Based on aggregate information from My MarketBeat watchlists, some companies that other STADA Arzneimittel Aktiengesellschaft investors own include ProSiebenSat.1 Media (PSM), Renault (RNO), Sarepta Therapeutics (SRPT), Volkswagen Aktiengesellschaft (VLKAY), Volkswagen (VOW3), ACADIA Pharmaceuticals (ACAD), Adverum Biotechnologies (ADVM), Aimmune Therapeutics (AIMT), Andersons (ANDE) and ANI Pharmaceuticals (ANIP). This page (ETR:SAZ) was last updated on 6/3/2024 by MarketBeat.com Staff From Our PartnersNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemWeiss RatingsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaAre You Positioned For The New Energy Goldrush?Wealthpin ProNext President (Not Trump. Not Biden.)The Freeport SocietyCollapse of the Petrodollar Colonial Metals[Webinar] Understanding Covered CallsOICWhat’s Pelosi Buying Now?AltimetryAlex's "Next Magnificent Seven" StocksThe Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding STADA Arzneimittel Aktiengesellschaft Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.